CELGENE

CELGENE

Displaying 10 out of 22 results

  1. Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an emplo

    Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug

    Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug ...
  2. File photo of an Amgen sign at the company's office in South San Francisco

    Amgen to buy Celgene psoriasis drug Otezla for US$13.4 billion

    Amgen Inc said on Monday it would buy Celgene Corp's psoriasis drug Otezla for US$13.4 billion in cash, clearing the way for Bristol-Myers ...
  3. New Content Item

    FDA approves Celgene's bone marrow cancer treatment

  4. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers plans to divest Celgene's psoriasis drug

    Bristol-Myers Squibb Co said on Monday it would divest Celgene Corp's psoriasis treatment Otezla as the companies look to gain approval for their ...
  5. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headqu

    Bristol-Myers profit slightly tops Wall Street view on blood thinner sales

    U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for US$74 billion, posted slightly ...
  6. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headqu

    Bristol-Myers says shareholders vote to approve Celgene takeover

    Bristol-Myers Squibb Inc's shareholders voted to approve the drugmaker's US$74 billion takeover of biotech Celgene Corp on Friday despite a ...
  7. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal

    Proxy advisory firm Institutional Shareholder Services on Friday recommended shareholders of drugmaker Bristol-Myers Squibb Co shareholders vote ...
  8. New Content Item

    US patent court rejects Alvogen's challenge for Celgene's Revlimid

  9. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers tells opponents Celgene deal is 'best path'

    U.S. drugmaker Bristol-Myers Squibb urged shareholders on Wednesday to support its planned takeover of Celgene Corp, as it faces opposition to the ...